U.K. Drug Regulator Follows U.S. FDA; Seeks Closer Ties With India's DCGI
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Following U.S. FDA's moves to work closely with the Drug Controller General of India - the Indian drug regulator - the United Kingdom's Medicines and Healthcare products Regulatory Agency has held discussions with the Indian health department officials to build closer relationships